医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

DaVita Begins Treating Kidney Patients in Malaysia

2012年12月03日 PM08:25
このエントリーをはてなブックマークに追加


 

DENVER & KUALA LUMPUR, Malaysia

DaVita (NYSE:DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced the acquisition of Tulips Dialysis Centre and has opened two new joint venture centers in Malaysia.

“We’re very pleased to bring to Malaysia DaVita’s commitment to our patients’ quality of life,” said Dennis Kogod, chief operating officer at DaVita.

Tulips Dialysis, a hemodialysis center located in Kota Damansara, 20 kilometers east of Kuala Lumpur, has capacity for 10 stations and is currently treating patients. Medical supervision is provided by nephrologist Dr. Wong Chew Ming.

Additionally, along with joint venture partner Seri Setia Group, DaVita has opened its doors to patients at two new centers in the greater Kuala Lumpur area – a 19-station center located in central Kuala Lumpur, and a six-station center located in Rawang, Selangor.

“DaVita’s expansion into Malaysia is an exciting step in the company’s long-term international expansion plans,” said Atul Mathur, president of Asia Pacific at DaVita.

As a leading provider of kidney care services in the United States, DaVita has achieved clinical outcomes that have improved year-over-year for more than a decade and plans to bring that track record of sustained clinical excellence to Malaysia.

For more information on DaVita please visit www.DaVita.com.

DaVita® is a registered trademark of DaVita HealthCare Partners Inc. All other trademarks are the property of their respective owners.

About DaVita

DaVita is the dialysis division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of kidney care in the United States, DaVita delivers dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of September 30, 2012, DaVita operated or provided administrative services at 1,912 outpatient dialysis centers located in the United States serving approximately 150,000 patients. The company also operated 24 outpatient dialysis centers located in five countries outside the United States. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com.

CONTACT

DaVita
Skip Thurman, 303-876-6610
Mobile: 720-300-0041
Skip.Thurman@davita.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent
  • Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
  • 三叶草生物制药完成6,280万元人民币A轮融资
  • Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.